BR0116856A - Composição de estrogênio e outros hormÈnios com ascorbato, lisina, prolina e outras substâncias - Google Patents

Composição de estrogênio e outros hormÈnios com ascorbato, lisina, prolina e outras substâncias

Info

Publication number
BR0116856A
BR0116856A BR0116856-8A BR0116856A BR0116856A BR 0116856 A BR0116856 A BR 0116856A BR 0116856 A BR0116856 A BR 0116856A BR 0116856 A BR0116856 A BR 0116856A
Authority
BR
Brazil
Prior art keywords
lysine
substances
ascorbate
estrogen
proline
Prior art date
Application number
BR0116856-8A
Other languages
English (en)
Inventor
Matthias Rath
Aleksandra Niedzwiecki
Vadim Ivanov
Shrirang Netke
Waheed M Roomi
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of BR0116856A publication Critical patent/BR0116856A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçãO DE ESTROGêNIO E OUTROS HORMÈNIOS COM ASCORBATO, LISINA, PROLINA E OUTRAS SUBSTâNCIAS". Essa invenção está relacionada a composições de estrogênio e hormónios relacionados em combinação com ascorbato, lisina, prolina e outras substâncias que afetam tecidos conjuntivos, sua capacidade e seu uso em contracepção, terapia de reposição hormonal durante a menopausa, e para outro uso em medicina, fisiologia, farmacologia, aplicações farmacêuticas e cosméticas.
BR0116856-8A 2001-12-14 2001-12-14 Composição de estrogênio e outros hormÈnios com ascorbato, lisina, prolina e outras substâncias BR0116856A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2001/014726 WO2003051371A1 (en) 2001-12-14 2001-12-14 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances

Publications (1)

Publication Number Publication Date
BR0116856A true BR0116856A (pt) 2004-08-03

Family

ID=8164723

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0116856-8A BR0116856A (pt) 2001-12-14 2001-12-14 Composição de estrogênio e outros hormÈnios com ascorbato, lisina, prolina e outras substâncias

Country Status (22)

Country Link
EP (1) EP1453520B1 (pt)
JP (1) JP2005511768A (pt)
KR (1) KR20040063950A (pt)
CN (1) CN1582152A (pt)
AT (1) ATE338555T1 (pt)
AU (1) AU2002233257B2 (pt)
BR (1) BR0116856A (pt)
CA (1) CA2467964C (pt)
CZ (1) CZ2004809A3 (pt)
DE (1) DE60122943T2 (pt)
DK (1) DK1453520T3 (pt)
EE (1) EE200300310A (pt)
ES (1) ES2272555T3 (pt)
HR (1) HRP20040611B1 (pt)
HU (1) HUP0500896A3 (pt)
IL (1) IL162013A0 (pt)
MX (1) MXPA04005771A (pt)
NO (1) NO20033555L (pt)
NZ (1) NZ532976A (pt)
PT (1) PT1453520E (pt)
SI (1) SI21785A (pt)
WO (1) WO2003051371A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253319A1 (en) * 2003-06-11 2004-12-16 Shrirang Netke Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy
KR100903984B1 (ko) * 2005-02-01 2009-06-25 주식회사 이매진 Aimp1 폴리펩티드 또는 이의 단편을 유효성분으로 포함하는 피부 노화 방지, 주름 개선, 피부 유연 증진 및 탄력 증진용 화장료 조성물
WO2008139314A1 (en) * 2007-05-11 2008-11-20 Horphag Research (Luxembourg) Holding Sa Compositions and methods for treating joint disorders
WO2010146078A2 (en) * 2009-06-16 2010-12-23 Bergen Teknologioverføring As Novel uses of hydroxyproline compositions
EP2857028A4 (en) * 2012-05-25 2016-04-06 Lion Corp AGENT CONTAINING ASCORBIC ACID DERIVATIVE AND USE THEREOF
JP6125899B2 (ja) * 2012-05-25 2017-05-10 ライオン株式会社 骨粗鬆症予防および／または改善剤
JP6018800B2 (ja) * 2012-05-25 2016-11-02 ライオン株式会社 経口投与組成物
CN113244227B (zh) * 2020-02-12 2022-09-02 浙江医药股份有限公司新昌制药厂 一种17β-雌二醇与维生素C的分子复合物及其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB888631A (en) * 1959-02-24 1962-01-31 Upjohn Co Improvements in or relating to oral therapeutic compositions comprising steroids
US4980358A (en) * 1988-04-04 1990-12-25 George D. McAdory Method employing gonadal hormones and dopamine agonist intended for combined use in the improvement of lymphocyte function
CA2078804C (en) * 1991-10-01 2003-02-25 Takehiko Suzuki Manufacture and use of novel glycosides of catechol estrogens
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
DE29916231U1 (de) * 1999-09-15 2000-02-17 Renner Jobst Multivitamin- und -mineralpräparat

Also Published As

Publication number Publication date
CA2467964C (en) 2008-06-03
HUP0500896A2 (en) 2007-02-28
CZ2004809A3 (cs) 2004-12-15
CN1582152A (zh) 2005-02-16
EP1453520A1 (en) 2004-09-08
NZ532976A (en) 2006-02-24
KR20040063950A (ko) 2004-07-14
NO20033555L (no) 2003-10-02
SI21785A (sl) 2005-12-31
WO2003051371A1 (en) 2003-06-26
DE60122943D1 (de) 2006-10-19
AU2002233257B2 (en) 2008-08-14
MXPA04005771A (es) 2004-09-10
IL162013A0 (en) 2005-11-20
DK1453520T3 (da) 2007-01-15
DE60122943T2 (de) 2007-04-26
ES2272555T3 (es) 2007-05-01
AU2002233257A1 (en) 2003-06-30
HUP0500896A3 (en) 2008-04-28
EP1453520B1 (en) 2006-09-06
JP2005511768A (ja) 2005-04-28
PT1453520E (pt) 2006-12-29
ATE338555T1 (de) 2006-09-15
HRP20040611A2 (en) 2005-04-30
HRP20040611B1 (en) 2008-03-31
CA2467964A1 (en) 2003-06-26
NO20033555D0 (no) 2003-08-11
EE200300310A (et) 2003-10-15

Similar Documents

Publication Publication Date Title
HUP0300335A2 (hu) 8béta-hidrokarbil-szubsztituált ösztratriének mint szelektív hatású ösztrogének, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
EA200201000A1 (ru) Гормон-заместительная терапия
BRPI0416924A (pt) preparação farmacêutica para tratamento hormonal contìnuo durante um perìodo de mais do que 21-28 dias compreendendo duas composições de estrogênio e/ou progestina
BR9915285A (pt) Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
BR9908094A (pt) Preparado combinado de estrogênio e antiestrogênio
PE20040157A1 (es) Progestinas no esteroides
EA200301022A1 (ru) Гормональная заместительная терапия
BR0116856A (pt) Composição de estrogênio e outros hormÈnios com ascorbato, lisina, prolina e outras substâncias
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
BR0110129A (pt) Composição farmacêutica
AR005860A1 (es) Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización.
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
EA200301023A1 (ru) Заместительная терапия эстрогенами
EA200100828A1 (ru) 16-гидроксиэстратриены в качестве эстрогенов избирательного действия
CR6398A (es) Antagonistas de 5ht1 para terapia antidepresiva
AR004502A1 (es) Una asociacion trisecuencial hormonal, estroprogestativa, su utilizacion y un procedimiento para su preparacion
TR199801915T2 (xx) Benzotiofenler, bunlar� ihtiva eden form�lasyonlar ve y�ntemler.
NO20010537D0 (no) Farmasöytiske preparater omfattende ibuprofen og domperidon
BRPI0418017A (pt) medicamento compreendendo inibidores de pentraxina ptx3 longa
BR0306778A (pt) Derivados de carboxamidina e seu uso no tratamento de doenças vasculares
PT981363E (pt) Somatostatina e agonistas da somatostatina para reduzir o peso corporal
RS107004A (en) 9-alpha-substituted estratrienes as selectively active estrogen
EA201000097A1 (ru) 8-бета-замещенные эстратриены в качестве селективно активных эстрогенов
BRPI0606724A2 (pt) preparação farmacêutica para contracepção

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. E 9A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2077 DE 26/10/2010.